about
Radiogenomics of clear cell renal cell carcinoma: associations between CT imaging features and mutations.Are histopathological features of prostate cancer lesions associated with identification of extracapsular extension on magnetic resonance imaging?Tumor genetic analyses of patients with metastatic renal cell carcinoma and extended benefit from mTOR inhibitor therapyClinical value of fluorine-18 2-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in bladder cancer.Semi-automatic deformable registration of prostate MR images to pathological slicesDiffusion-weighted endorectal MR imaging at 3 T for prostate cancer: tumor detection and assessment of aggressiveness.Subcentimeter pulmonary nodules are not associated with disease progression in patients with renal cell carcinomaRadiogenomics of clear cell renal cell carcinoma: preliminary findings of The Cancer Genome Atlas-Renal Cell Carcinoma (TCGA-RCC) Imaging Research GroupInteractive Feature Space Explorer© for multi-modal magnetic resonance imaging.Preoperative nomograms incorporating magnetic resonance imaging and spectroscopy for prediction of insignificant prostate cancerNormal central zone of the prostate and central zone involvement by prostate cancer: clinical and MR imaging implications.Contrast-enhanced magnetic resonance angiography: evaluation of renal arteries in living renal transplant donors.Prostate Cancer: assessing the effects of androgen-deprivation therapy using quantitative diffusion-weighted and dynamic contrast-enhanced MRI.Value of the hemorrhage exclusion sign on T1-weighted prostate MR images for the detection of prostate cancerInterobserver variability of R.E.N.A.L., PADUA, and centrality index nephrometry score systems.Reducing the influence of b-value selection on diffusion-weighted imaging of the prostate: evaluation of a revised monoexponential model within a clinical settingThe incremental value of contrast-enhanced MRI in the detection of biopsy-proven local recurrence of prostate cancer after radical prostatectomy: effect of reader experience.Performance characteristics of MR imaging in the evaluation of clinically low-risk prostate cancer: a prospective study.Endorectal MR imaging before salvage prostatectomy: tumor localization and staging.Endorectal MR imaging in the evaluation of seminal vesicle invasion: diagnostic accuracy and multivariate feature analysis.Transition zone prostate cancers: features, detection, localization, and staging at endorectal MR imaging.Image artifacts on prostate diffusion-weighted magnetic resonance imaging: trade-offs at 1.5 Tesla and 3.0 Tesla.Motion correction of multi-b-value diffusion-weighted imaging in the liver.Imaging of uterine cancer.Imaging of prostate cancer.Interactive dedicated training curriculum improves accuracy in the interpretation of MR imaging of prostate cancer.Use of DWI in the Differentiation of Renal Cortical Tumors.An Arterial Based Complexity (ABC) Scoring System to Assess the Morbidity Profile of Partial Nephrectomy.Focal treatment or observation of prostate cancer: pretreatment accuracy of transrectal ultrasound biopsy and T2-weighted MRI.Transatlantic Consensus Group on active surveillance and focal therapy for prostate cancerDetection of prostate cancer with MR spectroscopic imaging: an expanded paradigm incorporating polyamines.Bevacizumab Monotherapy as Salvage Therapy for Advanced Clear Cell Renal Cell Carcinoma Pretreated With Targeted Drugs.Perihepatic metastases from ovarian cancer: sensitivity and specificity of CT for the detection of metastases with and those without liver parenchymal invasion.Prostate tumor volume measurement with combined T2-weighted imaging and diffusion-weighted MR: correlation with pathologic tumor volume.Clinical stage T1c prostate cancer: evaluation with endorectal MR imaging and MR spectroscopic imaging.Multiphasic contrast-enhanced MRI: single-slice versus volumetric quantification of tumor enhancement for the assessment of renal clear-cell carcinoma fuhrman grade.Bland and tumor thrombi in abdominal malignancies: magnetic resonance imaging assessment in a large oncologic patient population.Multimodality magnetic resonance imaging of prostate cancer.The value of MR imaging when the site of uterine cancer origin is uncertain.Imaging assessment of tumor response: past, present and future.
P50
Q33570946-0FE8DA92-C937-4EF9-8023-7B0ACD3B9236Q33699276-833258C6-A3AD-43E0-914B-7F91723E4050Q34074997-E22450CB-A1D8-440D-875C-83BBB101308FQ34131787-7E124184-8822-4534-83F8-F4EDAFB3B6AAQ34286215-0FE75B68-8837-4D47-8585-5DDEEB9EA8CCQ34995967-94672BB9-1CD5-420B-A4FB-8302470CEDE0Q35177397-9426F10C-6E95-4B04-A6C4-CC8C483838BEQ35574106-45028A0A-24E3-4CAF-9EA8-73AF8C176193Q35690565-8F6EA343-13E1-4344-9666-4F5AC5185622Q35722781-BD103771-F3DF-4410-AF96-83C19F5135A6Q35773547-F2C067DE-7179-4B2C-B508-41D1209C75CFQ35893939-CAD57C18-73BF-4D13-B260-92653421FACDQ35931475-2221EB5F-5D51-4972-9E2D-3454034EB60CQ35985579-946F0174-56F3-416C-B5CA-AA1D94052DECQ36015351-431F2E1A-50C0-42E0-BF40-5D56E442915DQ36182439-1220FAC6-DF9E-49B0-A6DC-6ADF43656243Q36290824-28FB0600-1D07-4E7C-A37D-25CEC793DB9FQ36346204-23BB032B-E6E4-427D-AE53-DF8282E57D05Q36351007-70A81026-F470-4C81-A085-0A2CA6C098B6Q36372949-C1C25401-ACC7-4178-ABDB-2DCC99F200DBQ36434291-04D02C20-7837-4A97-9EAA-405AB9E4D20DQ36487054-1DDB15EE-19BB-4E43-88B2-8870F0B9A18DQ36672755-BFB2F09D-C4FD-400C-BA80-DAECA8ADF898Q36678282-0EF71CDC-7350-4620-BD49-894482245621Q36678290-6B162AFF-8801-434F-BBE8-685DABE76448Q36721080-6FB3EE66-3DD1-41C1-9F76-036256987C41Q36783277-357598D9-0B23-4072-A108-BF9270680F6EQ36784240-0D3B970C-5B5F-4A05-81D2-DA1211ED3E54Q36837246-A0A040B1-CB12-4987-BCD9-62E39DBE6BA8Q36928846-F4327C52-839D-4A8F-A88F-47DDDB7E4B14Q36949507-5B10626E-313B-4841-BF99-8B7AF975C366Q37137116-413DE45D-EAD6-4D32-A552-145B78AC2DF8Q37179980-69FCCE2C-5238-474C-9C25-E9FC5DF99CDCQ37366891-A994962B-75DA-4C51-BE8B-F481F7009976Q37404915-348D7DC9-0A91-45F0-8569-33CD97BB12AAQ37708077-0E5526EE-8EA1-4A66-98DF-D1E39DDA1353Q37708145-58620187-CBB9-42FB-A632-2BA1E3555CEFQ37742636-B0FDC08A-C3AB-4EC3-B34F-99E1CC23FD13Q37826589-0165AF49-DFDC-4063-BA87-E3267F5B13BAQ37875082-4B6489E8-2EAC-4AA9-A699-629D79416CC0
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Oguz Akin
@ast
Oguz Akin
@en
Oguz Akin
@es
Oguz Akin
@nl
Oguz Akin
@sl
type
label
Oguz Akin
@ast
Oguz Akin
@en
Oguz Akin
@es
Oguz Akin
@nl
Oguz Akin
@sl
prefLabel
Oguz Akin
@ast
Oguz Akin
@en
Oguz Akin
@es
Oguz Akin
@nl
Oguz Akin
@sl
P106
P1153
7005769802
P21
P31
P496
0000-0002-2041-6199
P569
2000-01-01T00:00:00Z